Cgm clinical trials

Explore recruiting cgm clinical trials.

Recruiting cgm studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cgm trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effects of empagliflozin on plasma glucose in patients with HNF1A-MODY: a randomized, double-blind, crossover trial

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized placebo controlled clinical trial of preserving endogenous insulin production with Ixekizumab in newly diagnosed persons with type 1 diabetes

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase 2, multicenter, randomized, double-blind, placebo-controlled study to assess the effect and safety of 400 mg twice a day oral ladarixin in patients with recent onset type 1 diabetes and a low residual β-cell function at baseline.

Belgium, Germany, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

GSDIa Disease Monitoring Program

Netherlands, Spain, Denmark, Germany, Italy

Phase III and phase IV (Integrated) EU CTIS Study details

Safety and efficacy of oral semaglutide in hyperglycaemic patients after renal transplantation

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Up-titration of sulfonylurea (SU) in individuals with HNF1A- and HNF4A-MODY – A Steno MODERN-MODY project (MM-SUUP)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Cgm trials by city

Cgm in Toronto Cgm in Vancouver Cgm in Montreal Cgm in Calgary Cgm in Edmonton Cgm in Ottawa Cgm in Winnipeg Cgm in Quebec City Cgm in Hamilton Cgm in Kitchener Cgm in London Cgm in Halifax Cgm in New York Cgm in Los Angeles Cgm in Chicago Cgm in Houston

Cgm clinical trials

Recruiting cgm studies right now

Glucose Profiles in Women With Polycystic Ovary Syndrome

Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes

Electric Stimulation Home Use(CGM MEPC_2401) for Improving Blood Circulation

Stanford Pediatric Healthy Weight Index

Effect of Continuous Glucose Monitoring System on Glycemic Control in Non-insulin-Treated Elderly People With Type 2 Diabetes

Enhancing Digitally Delivered Diabetes Education With Real-Time CGM

The Intelligent Diabetes TelemonitoRing Using Decision Support to Treat Patients on Insulin Therapy

Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes

Continuous Bloodsugar Monitoring System With a Sensor Compared to Fingerstick Bloodsugar Monitoring

Acute Sauna Session and Glucose Control

Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge

Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma

Also recruiting in Europe

Effects of empagliflozin on plasma glucose in patients with HNF1A-MODY: a randomized, double-blind, crossover trial

A randomized placebo controlled clinical trial of preserving endogenous insulin production with Ixekizumab in newly diagnosed persons with type 1 diabetes

A phase 2, multicenter, randomized, double-blind, placebo-controlled study to assess the effect and safety of 400 mg twice a day oral ladarixin in patients with recent onset type 1 diabetes and a low residual β-cell function at baseline.

GSDIa Disease Monitoring Program

Safety and efficacy of oral semaglutide in hyperglycaemic patients after renal transplantation

Up-titration of sulfonylurea (SU) in individuals with HNF1A- and HNF4A-MODY – A Steno MODERN-MODY project (MM-SUUP)

Cgm trials by city

Other conditions